Works matching IS 20564538 AND DT 2025 AND VI 11 AND IP 1

Results: 6
    1

    Immunohistochemistry‐based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy.

    Published in:
    Journal of Pathology: Clinical Research, 2025, v. 11, n. 1, p. 1, doi. 10.1002/2056-4538.70017
    By:
    • Olah, Csilla;
    • Shmorhun, Oleksandr;
    • Klamminger, Gilbert Georg;
    • Rawitzer, Josefine;
    • Sichward, Lara;
    • Hadaschik, Boris;
    • Al‐Nader, Mulham;
    • Krafft, Ulrich;
    • Niedworok, Christian;
    • Váradi, Melinda;
    • Nyirady, Peter;
    • Kiss, Andras;
    • Szekely, Eszter;
    • Reis, Henning;
    • Szarvas, Tibor
    Publication type:
    Article
    2
    3
    4
    5

    Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer.

    Published in:
    Journal of Pathology: Clinical Research, 2025, v. 11, n. 1, p. 1, doi. 10.1002/2056-4538.70012
    By:
    • Gorbokon, Natalia;
    • Wößner, Niklas;
    • Ahlburg, Viktoria;
    • Plage, Henning;
    • Hofbauer, Sebastian;
    • Furlano, Kira;
    • Weinberger, Sarah;
    • Bruch, Paul Giacomo;
    • Schallenberg, Simon;
    • Roßner, Florian;
    • Elezkurtaj, Sefer;
    • Lennartz, Maximilian;
    • Blessin, Niclas C;
    • Marx, Andreas H;
    • Samtleben, Henrik;
    • Fisch, Margit;
    • Rink, Michael;
    • Slojewski, Marcin;
    • Kaczmarek, Krystian;
    • Ecke, Thorsten
    Publication type:
    Article
    6

    Issue Information.

    Published in:
    Journal of Pathology: Clinical Research, 2025, v. 11, n. 1, p. 1, doi. 10.1002/cjp2.12379
    Publication type:
    Article